1. Companies 'will take four YEARS' to manufacture enough coronavirus vaccine for the world  Daily Mail
  2. Germany boosts own vaccine makers in race for COVID-19 jab  Taiwan News
  3. Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will  The Conversation US
  4. China coronavirus vaccine may be ready for public in November: Official  The Straits Times
  5. Feds still open to China-made vaccines but relying on task force's advice: minister  iPolitics.ca
  6. View Full coverage on Google News
Chief executive officer at the Serum Institute of India, Adar Poonawalla, told the Financial Times companies don't have capacity to make enough doses for the entire world before 2024.Chief executive officer at the Serum Institute of India, Adar Poonawalla, told the Financial Times companies don't have capacity to make enough doses for the entire world before 2024.

Companies 'will take four YEARS' to manufacture enough coronavirus vaccine for the world | Daily Mail Online

An expanded arrangement with a local producer should allow for 2 billion doses to be manufactured annually.An expanded arrangement with a local producer should allow for 2 billion doses to be manufactured annually.

Novavax Doubling Coronavirus Vaccine Production Capacity With Expanded India Deal | The Motley Fool

Novavax, Inc. (NASDAQ: NVAX), which has a Phase 2 study underway of its coronavirus vaccine candidate NVX-CoV2373, is diligently working on partnerships to ...Novavax, Inc. (NASDAQ: NVAX), which has a Phase 2 study underway of its coronavirus vaccine candidate NVX-CoV2373, is diligently working on partnerships to boost its...

Novavax, Inc. (NASDAQ:NVAX) - Novavax Expands Coronavirus Vaccine Capacity To More Than 2B Doses In 2021 | Benzinga

As millions across the nation wait for a coronavirus vaccine to be administered, the chief executive of Serum Institute of India, the world’s biggest vaccine producer, suggested that once developed, a COVID-19 vaccine may not fully reach the population until 2024. The date is because [...]As millions across the nation wait for a coronavirus vaccine to be administered, the chief [...]

Coronavirus Vaccine Won't Be Available to Everyone Until 2024, CEO of World's Biggest Producer Says

At a time when the whole world is eagerly awaiting good news to fight the Coronavirus, Serum Institute of India CEO Adar Poonawalla expressed doubt thatAt a time when the whole world is eagerly awaiting good news to fight the Coronavirus, Serum Institute of India CEO Adar Poonawalla expressed doubt that

Vaccine Might Not Be Available To All Till 2024: Serum Institute CEO - Gulte

Hindustan TimesFrom the CEO of the world’s largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be ‘tougher’ - here are the top news updates on the Covid-19 pandemic. Adar Poonawalla, chief executive of Serum Institute of India reportedly said that it might take 4-5 years for the vaccine to reach everyone. He estimated that around 1,500 crore vaccine doses would be required to inoculate everyone if the final vaccine is a 2-dose drug. Meanwhile, the Government of India banned the export of onions after a 30% jump in export of the kitchen staple in the April-July 2020 period. Over a dozen Members of Parliament were found to be Covid positive on the day the central legislative body convened for its monsoon session. In Delhi, the deputy Chief Minister, Manish Sisodia, tested positive on the day that the Chief Minister of neighbouring Haryana, Manohar Lal Khattar, finally recovered from the disease. Watch the full video for the other top updates on the spread of the Sars-CoV-2 coronavirus.Hindustan TimesFrom the CEO of the world’s largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be ‘tougher’ - here are the top news updates on the Covid-19 pandemic. Adar Poonawalla, chief executive of Serum Institute of India reportedly said that it might take 4-5 years for the vaccine to reach everyone. He estimated that around 1,500 crore vaccine doses would be required to inoculate everyone if the final vaccine is a 2-dose drug. Meanwhile, the Government of India banned the export of onions after a 30% jump in export of the kitchen staple in the April-July 2020 period. Over a dozen Members of Parliament were found to be Covid positive on the day the central legislative body convened for its monsoon session. In Delhi, the deputy Chief Minister, Manish Sisodia, tested positive on the day that the Chief Minister of neighbouring Haryana, Manohar Lal Khattar, finally recovered from the disease. Watch the full video for the other top updates on the spread of the Sars-CoV-2 coronavirus.

Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning - coronavirus-crisis - videos - Hindustan Times

corona vaccine available in india - Covid-19 vaccine, Serum Institute's big announcement on coronavirus vaccine will not be available for everybody in the world to be immunised until the end of 2024.In a big blow to the expectations regarding the covid-19 vaccine, the Serum Institute of India has said adequate coronavirus vaccine will not be available for everybody in the world to be immunised until the end of 2024. The chief executive of the world’s largest manufacturer of vaccines, Adar Poonawalla, has said dampened the hopes of a COVID-19 vaccine by year-end in an interview with the Financial Times. He said that pharma firms were not ramping up production capacity swiftly to be able to innoculate the world population in less duration.

Coronavirus vaccine won’t be available to everyone before 2024 end: India's Serum Institute chief, India News News | wionews.com

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won’t Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won't Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India. As part of the expanded agreement, Serum Institute will also manufactureIn August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India. As part of the expanded agreement, Serum Institute will also manufacture

Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal

The world's biggest vaccine producer, the Serum Institute of India, has warned it will take until at least 2024 to make enough vaccines to go around.The world's biggest vaccine producer, the Serum Institute of India, has warned it will take until at least 2024 to make enough vaccines to go around.

COVID-19 vaccine won't reach everyone until 2024: Serum Institute of India - Business Insider

Maybe the wait is worth it! Click here to see why a viable coronavirus vaccine might not come fast.Maybe the wait is worth it! Click here to see why a viable coronavirus vaccine might not come fast.

Coronavirus Vaccine - No Rest From COVID-19 Until 2024? | IE

Access to this page has been denied.

Serum Institute, which is in Pune, has partnered with five international pharmaceutical companies, including AstraZeneca and Novavax, to develop a vaccine and pledged to manufacture one billion doses, out of which it has promised 50% to India.Serum Institute, which is in Pune, has partnered with five international pharmaceutical companies, including AstraZeneca and Novavax, to develop a vaccine and pledged to manufacture one billion doses, out of which it has promised 50% to India.

Coronavirus Vaccine Won’t Be Available to Everyone Before End of 2024, Says Serum Institute Chief

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial. The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial. The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be

Serum Institute Of India Gets DCGI Nod To Resume Clinical Trial Of Oxford COVID-19 Vaccine

The CEO of Serum Institute of India, Adar Poonawalla, speaking to the media has stated that it will take at least four years to make coronavirus vaccines which will be adequate for the entire world.According to Financial Times, he stated that the long wait was due to the fact that pharmaceutical companies were not ramping up their production levels quickly enough to vaccinate the global population in less time. Moreover, he added that the world will need 15 billion doses of vaccine if it is taken in two steps.The Serum Institute of India (SII) had earlier initiated human trials for its much talked about ‘Covishield’ vaccine. This vaccine is jointly developed by the University of Oxford and AstraZeneca and is considered to be one of the leading candidates to make the final cut.The first patients for Covishield’s human trials were screened and approved by Pune’s Bharati Vidyapeeth Deemed University Medical College and Hospital. It is said that the hospital aims to have up to 300 to 350 participants for this trial.Positioned to be at the forefront of India’s COVID-19 vaccine push, Serum Institute is the world’s largest vaccine manufacturer by volume, producing doses of vaccines annually for use in more than 170 countries to protect against many infectious diseases, such as polio, measles and influenza.The CEO of Serum Institute of India, Adar Poonawalla, speaking to the media has stated that it will take at least four years to make coronavirus vaccines which will be adequate for the entire world.According to Financial Times, he stated that the long wait was due to the fact that pharmaceutical companies were not ramping up their production levels quickly enough to vaccinate the global population in less time. Moreover, he added that the world will need 15 billion doses of vaccine if it is taken in two steps.The Serum Institute of India (SII) had earlier initiated human trials for its much talked about ‘Covishield’ vaccine. This vaccine is jointly developed by the University of Oxford and AstraZeneca and is considered to be one of the leading candidates to make the final cut.The first patients for Covishield’s human trials were screened and approved by Pune’s Bharati Vidyapeeth Deemed University Medical College and Hospital. It is said that the hospital aims to have up to 300 to 350 participants for this trial.Positioned to be at the forefront of India’s COVID-19 vaccine push, Serum Institute is the world’s largest vaccine manufacturer by volume, producing doses of vaccines annually for use in more than 170 countries to protect against many infectious diseases, such as polio, measles and influenza.

COVID-19 vaccine distribution could take 4 years: Adar Poonawalla | Mumbai

Serum Institute of India chief Adar Poonawalla has said there won't be enough vaccines available for everybody on the planet until 2024 end.  Poonawalla, CEO of the world's largest vaccine maker, said, if vaccination involved two-doses, 15 billion shots will be required to make it available for everybody. "It’s going to take four to five years until everyone gets the vaccineSerum Institute of India chief Adar Poonawalla has said there won't be enough vaccines available for everybody on the planet until 2024 end.  Poonawalla, CEO of the world's largest vaccine maker,

There won't be enough Covid-19 vaccines till 2024, says Serum Institute's Adar Poonawalla | Deccan Herald

The entire world is racing to develop a coronavirus vaccine but that doesn’t mean everyone across the globe will have access to it anytime soon.The entire world is racing to develop a coronavirus vaccine but that doesn’t mean everyone across the globe will have access to it anytime soon.

Experts warn it might take up to four years to supply COVID-19 vaccine globally

Serum Institute's big announcement on coronavirus vaccine, here's when you will get first dose of COVID-19 vaccine - The Serum Institute is working with 5 international companies to develop the coronavirus vaccine.Serum Institute's big announcement on coronavirus vaccine, here's when you will get first dose of COVID-19 vaccine - The Serum Institute is working with 5 international companies to develop the coronavirus vaccine.

Serum Institute's big announcement on coronavirus vaccine, here's when you will get first dose of COVID-19 vaccine

Despite a lackluster history of taking vaccines to market, Maryland's Novavax is streaking through clinical trials for its promising COVID-19 shot candidate. Going commercial is a whole other beast, however, and Novavax is now expanding one of its key manufacturing deals to aid the cause. Despite a lackluster history of taking vaccines to market, Maryland's Novavax is streaking through clinical trials for its promising COVID-19 shot candidate. Going commercial is a whole other beast, however, and Novavax is now expanding one of its key manufacturing deals to aid the cause. 

Novavax adds antigens to COVID-19 production pact with Indian vaccines giant | FiercePharma

Pharmaceutical companies not increasing capacity quickly enough – Serum Institute chief executive saysPharmaceutical companies not increasing capacity quickly enough – Serum Institute chief executive says

Not enough Covid-19 vaccine for all until 2024, says biggest producer

The chief executive of the world's largest vaccine manufacturer says it will take about four or five years to produce enough COVID-19 vaccines to inoculate everyone in the world.

Pharma CEO warns that millions worldwide won't get COVID vaccine until 2024 - SFGate

The chief executive of the world’s largest vaccine producer is cautioning that the world’s population may not be fully vaccinated against the coronavirus until at least the end of 2024, he said in an interview with the Financial Times.The chief executive of the world’s largest vaccine producer is cautioning that the world’s population may not be fully vaccinated against the coronavirus until at least the end of 2024, he said in an interview with the Financial Times.

Vaccine producer says it could take ‘four to five years’ for the world to receive a COVID-19 dose - The Boston Globe

Vaccine Update: Biotechnology company Novavax on Tuesday announced an agreement with Serum Institute of India to manufacture and deliver Coronavirus Vaccine.Vaccine Update: Biotechnology company Novavax on Tuesday announced an agreement with Serum Institute of India to manufacture and deliver Coronavirus Vaccine.

Novavax- Serum Institute Come Together To Manufacture 'NVX‑CoV2373' COVID Vaccine; Aim To Increase Production To Over 2 Billion Doses

It's going to take four to five years until everyone gets the vaccine on this planet, Poonawalla said. He said the vaccine may require two doses, which means there will need to be upward of 15 billion doses made available.It could be another five years before the entire world is vaccinated for COVID-19, the CEO of the largest vaccine manufacturer in the world said. Adar Poonawalla, who runs the Serum Institute of India, spoke with the Financial Times and said the challenge of inoculating the...

Vaccine Maker: Vaccinating Entire World for COVID-19 May Take 5 Years | Newsmax.com

As a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate.US-based Novavax's vaccine is in mid-stage trials after an early-stage trial showed it produced high levels of antibodies against the novel coronavirusAs a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate.US-based Novavax's vaccine is in mid-stage trials after an early-stage trial showed it produced high levels of antibodies against the novel coronavirus

Novavax-Serum Institute to produce for 200 crore Covid-19 vaccine doses

he CEO highlighted the discrepancies and hurdles vaccine companies face in producing a vaccine for the masses. Adding that the world cannot depend on a vaccine alonehe CEO highlighted the discrepancies and hurdles vaccine companies face in producing a vaccine for the masses. Adding that the world cannot depend on a vaccine alone

Coronavirus vaccine update: COVID-19 vaccine distribution would take 4-5 years, says SII CEO Adar Poonawallah | The Times of India

he CEO highlighted the discrepancies and hurdles vaccine companies face in producing a vaccine for the masses. Adding that the world cannot depend on a vaccine alonehe CEO highlighted the discrepancies and hurdles vaccine companies face in producing a vaccine for the masses. Adding that the world cannot depend on a vaccine alone

Coronavirus vaccine update: COVID-19 vaccine distribution would take 4-5 years, says SII CEO Adar Poonawallah | The Times of India

According to sources, on Monday Adar Poonawalla, CEO of the Serum Institute of India, warned that there would not be enough coronavirus vaccines available inAccording to sources, on Monday Adar Poonawalla, CEO of the Serum Institute of India, warned that there would not be enough coronavirus vaccines available in

COVID-19 Vaccine Latest Update: By 2024, There Will Not Be Enough Vaccines Available To Everyone! | Inventiva

Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing coronavirus vaccine, has said the dose will not be available for the entire world before the end of 2024Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing coronavirus vaccine, has said the dose will not be available for the entire world before the end of 2024

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

Serum Institute of India CEO Adar Poonawalla says it would take at least four to five years to immunise the world against COVID-19, the disease caused by the novel coronavirus.Serum Institute of India CEO Adar Poonawalla says it would take at least four to five years to immunise the world against COVID-19, the disease caused by the novel coronavirus.

Read more about Not enough Covid-19 vaccines for everybody till 2024 end: Adar Poonawalla on Business Standard. Poonawalla estimates that the world will need 15 billion doses of the vaccine if it is taken in two stepsPoonawalla estimates that the world will need 15 billion doses of the vaccine if it is taken in two steps

Not enough Covid-19 vaccines for everybody till 2024 end: Adar Poonawalla | Business Standard News

NEW DELHI: As the world is grappling with the pandemic and is eagerly waiting for the official announcement of a vaccine for COVID-19, the chief executive of the world’s largest vaccine manufacturing firm Mr. Adar Poonawalla has said that there isn't

Coronavirus Vaccine Won’t Be Available to Everyone Before End of 2024, says Serum Institute Chief – The Shillong Times

Twenty-five MPs tested positive for the coronavirus. Twenty-five MPs tested positive for the coronavirus.

Coronavirus LIVE: Won’t be enough vaccines for whole world for 4 to 5 years, says Adar Poonawalla

Twenty-five MPs tested positive for the coronavirus. Twenty-five MPs tested positive for the coronavirus.

Coronavirus LIVE: Won’t be enough vaccines for whole world for 4 to 5 years, says Adar Poonawalla

Serum Institute, Serum Institute CEO, Adar Poonawalla, Coronavirus vaccine won’t be available to everyone before end of 2024, covid vaccine, coronavirus vaccine update, The chief executive of the world’s largest manufacturer of vaccines, Serum Institute has said that adequate coronavirus vaccine will not be available for everybody in the world to be immunised until the end of 2024.

Coronavirus vaccine won’t be available to everyone before end of 2024: Serum Institute CEO Adar Poonawalla | India News – India TV

CEO of Serum Institute Adar Poonawalla said also raised concerns about vaccine distribution in India given the country’s poor cold chain infrastructure to transport the vaccine safelyCEO of Serum Institute Adar Poonawalla said also raised concerns about vaccine distribution in India given the country’s poor cold chain infrastructure to transport the vaccine safely

Coronavirus vaccine | Current production not enough, will take 4-5 years to vaccinate everyone, says Adar Poonawalla

Will take 4-5 years before everyone on the planet can access the vaccine: PoonawallaWill take 4-5 years before everyone on the planet can access the vaccine: Poonawalla

COVID-19 vaccine won’t be available for all until 2024: Serum Institute CEO - The Week

Other drugmakers such as Pfizer Inc and Moderna Inc have already begun large late-stage studies of their experimental vaccines.Other drugmakers such as Pfizer Inc and Moderna Inc have already begun large late-stage studies of their experimental vaccines.

Novavax aims for 2 bln COVID-19 vaccine doses with expanded India deal - The Peninsula Qatar

As part of the expanded agreement, Serum Institute will also manufacture the antigen component of the vaccine, which is dubbed NVX‑CoV2373.As part of the expanded agreement, Serum Institute will also manufacture the antigen component of the vaccine, which is dubbed NVX‑CoV2373.

Novavax aims for two billion COVID-19 vaccine doses with expanded Serum Institute deal - India News

US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.

US Firm Novavax Aims For 2 Billion Coronavirus Vaccine Doses With Expanded India Deal